Continuous Glucose Monitoring Systems Market by Component, Demographics, Patient Type, End User, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation

Description

List of Tables

The Global Continuous Glucose Monitoring Systems Market is forecasted to grow significantly, with a projected USD 5,546.70 million in 2023 at a CAGR of 12.31% and expected to reach a staggering USD 12,553.85 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Continuous Glucose Monitoring Systems Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Continuous Glucose Monitoring Systems Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Integrated Insulin Pumps, Sensors, and Transmitters & Receivers. The Integrated Insulin Pumps commanded largest market share of 39.29% in 2022, followed by Transmitters & Receivers.

Based on Demographics, market is studied across Adult Population and Children Population. The Adult Population commanded largest market share of 88.10% in 2022, followed by Children Population.

Based on Patient Type, market is studied across Type 1 Diabetes and Type 2 Diabetes. The Type 2 Diabetes commanded largest market share of 34.73% in 2022, followed by Type 1 Diabetes.

Based on End User, market is studied across Diagnostic Centers & Clinics, Home Healthcare, and ICUs. The ICUs commanded largest market share of 35.38% in 2022, followed by Diagnostic Centers & Clinics.

Based on Distribution Channel, market is studied across Institutional Sales and Retail Sales. The Retail Sales commanded largest market share of 83.53% in 2022, followed by Institutional Sales.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 35.70% in 2022, followed by Asia-Pacific.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Continuous Glucose Monitoring Systems Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Continuous Glucose Monitoring Systems Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Continuous Glucose Monitoring Systems Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Continuous Glucose Monitoring Systems Market?

4. What is the competitive strategic window for opportunities in the Global Continuous Glucose Monitoring Systems Market?

5. What are the technology trends and regulatory frameworks in the Global Continuous Glucose Monitoring Systems Market?

6. What is the market share of the leading vendors in the Global Continuous Glucose Monitoring Systems Market?

7. What modes and strategic moves are considered suitable for entering the Global Continuous Glucose Monitoring Systems Market?

Product Code: MRR-43676CF42303

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Continuous Glucose Monitoring Systems Market, by Component, 2022 vs 2030
4.3. Continuous Glucose Monitoring Systems Market, by Demographics, 2022 vs 2030
4.4. Continuous Glucose Monitoring Systems Market, by Patient Type, 2022 vs 2030
4.5. Continuous Glucose Monitoring Systems Market, by End User, 2022 vs 2030
4.6. Continuous Glucose Monitoring Systems Market, by Distribution Channel, 2022 vs 2030
4.7. Continuous Glucose Monitoring Systems Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Number of Incidence of Diabetic Patients Globally
  - 5.1.1.2. Growing Regulatory Approvals for the CGM Systems
  - 5.1.1.3. Growing Adoption Rate of CGM Systems in Home Healthcare
- 5.1.2. Restraints
  - 5.1.2.1. Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
- 5.1.3. Opportunities
  - 5.1.3.1. Technological Advancements and Increased Awareness of CGM Systems
  - 5.1.3.2. Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
- 5.1.4. Challenges
  - 5.1.4.1. Reimbursement and Stringent Regulatory Issues
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Continuous Glucose Monitoring Systems Market, by Component

6.1. Introduction
6.2. Integrated Insulin Pumps
6.3. Sensors
6.4. Transmitters & Receivers

7. Continuous Glucose Monitoring Systems Market, by Demographics

7.1. Introduction
7.2. Adult Population
7.3. Children Population

8. Continuous Glucose Monitoring Systems Market, by Patient Type

8.1. Introduction
8.2. Type 1 Diabetes
8.3. Type 2 Diabetes

9. Continuous Glucose Monitoring Systems Market, by End User

9.1. Introduction
9.2. Diagnostic Centers & Clinics
9.3. Home Healthcare
9.4. ICUs

10. Continuous Glucose Monitoring Systems Market, by Distribution Channel

10.1. Introduction
10.2. Institutional Sales
10.3. Retail Sales

11. Americas Continuous Glucose Monitoring Systems Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Continuous Glucose Monitoring Systems Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing